CD4 and HIV-1 infection: In an attempt to compare the ability of DCs once treated with PAMPs to sensitize autologous CD4+ T cells that are resting before initiation of the co-culture to productive HIV-1 infection, we first measured the presence of activation markers on the surface of CD4+ T cells.